Works about THERAPEUTIC use of antineoplastic agents

Results: 5000
    1
    2

    Alzheimer Disease in Breast Cancer Survivors.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 6, p. e2516468, doi. 10.1001/jamanetworkopen.2025.16468
    By:
    • Jeong, Su-Min;
    • Jung, Wonyoung;
    • Cho, Hyeonjin;
    • Choi, Hea Lim;
    • Jeon, Keun Hye;
    • Nam, Ki-Woong;
    • Lee, Yun-Gyoo;
    • Kim, Bongseong;
    • Han, Kyungdo;
    • Shin, Dong Wook
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Importance of E/e' and BNP for early detection of late cardiotoxicity in long-term follow-up of childhood hematologic cancer survivors: a retrospective cross-sectional study.

    Published in:
    Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00354-1
    By:
    • Okazoe-Hirakawa, Yuri;
    • Yakushijin, Kimikazu;
    • Kurata, Keiji;
    • Matsumoto, Sakuya;
    • Ichikawa, Hiroya;
    • Sakai, Rina;
    • Nose, Taku;
    • Kimbara, Shiro;
    • Nagatani, Yoshiaki;
    • Koyama, Taiji;
    • Inui, Yumiko;
    • Funakoshi, Yohei;
    • Kiyota, Naomi;
    • Ito, Mitsuhiro;
    • Hatazawa, Keiko;
    • Tanaka, Hidekazu;
    • Yamamoto, Nobuyuki;
    • Minami, Hironobu
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Cosibelimab.

    Published in:
    American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
    Publication type:
    Article
    22

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    23

    Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 456, doi. 10.1159/000541018
    By:
    • Persano, Mara;
    • Casadei-Gardini, Andrea;
    • Tada, Toshifumi;
    • Suda, Goki;
    • Shimose, Shigeo;
    • Kudo, Masatoshi;
    • Rossari, Federico;
    • Yoo, Changhoon;
    • Cheon, Jaekyung;
    • Finkelmeier, Fabian;
    • Lim, Ho Yeong;
    • Presa, José;
    • Masi, Gianluca;
    • Bergamo, Francesca;
    • Amadeo, Elisabeth;
    • Vitiello, Francesco;
    • Kumada, Takashi;
    • Sakamoto, Naoya;
    • Iwamoto, Hideki;
    • Aoki, Tomoko
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Clinical and Histological Predictors of Advanced Basal Cell Carcinoma Recurrence After Complete Response to Hedgehog Pathway Inhibitors: A Retrospective Multicenter Observational Study.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1840, doi. 10.3390/cancers17111840
    By:
    • Mannino, Maria;
    • Scalvenzi, Massimiliano;
    • Di Stefani, Alessandro;
    • Costa, Claudia;
    • Calzavara-Pinton, Piergiacomo;
    • Fargnoli, Maria Concetta;
    • Piccerillo, Alfredo;
    • Bocchino, Enrico;
    • Zalaudek, Iris;
    • Ascierto, Paolo Antonio;
    • Quaglino, Pietro;
    • Queirolo, Paola;
    • Dika, Emi;
    • De Giorgi, Vincenzo;
    • Moscarella, Elvira;
    • Bianchi, Luca;
    • Longo, Caterina;
    • Cantisani, Carmen;
    • Villani, Alessia;
    • Peris, Ketty
    Publication type:
    Article
    33

    Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1830, doi. 10.3390/cancers17111830
    By:
    • King, Gentry G.;
    • Baker, Kelsey K.;
    • Coveler, Andrew L.;
    • Harris, William P.;
    • Cohen, Stacey A.;
    • Shankaran, Veena;
    • Zhen, David B.;
    • Safyan, Rachael A.;
    • Lee, Hannah H.;
    • Alidina, Annie;
    • Hensel, Jeniece;
    • Hibbert, Reina;
    • Durm, Greg A.;
    • LaFary, Yvonne C.;
    • Younger, Anne;
    • Kugel, Sita;
    • Collisson, Eric;
    • Konnick, Eric Q.;
    • Redman, Mary W.;
    • Schneider, Bryan P.
    Publication type:
    Article
    34
    35
    36
    37
    38

    Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1797, doi. 10.3390/cancers17111797
    By:
    • Yu, James;
    • Laborde, Jose M.;
    • Park, Robin;
    • Shahzad, Moazzam;
    • Kim, Youngchul;
    • Cheon, Jaekyung;
    • Imanirad, Iman;
    • Kim, Richard D.;
    • Biachi de Castria, Tiago;
    • Nardella, Nicole L.;
    • Malafa, Mokenge;
    • Denbo, Jason W.;
    • Fleming, Jason B.;
    • Hoffe, Sarah E.;
    • Frakes, Jessica M.;
    • Sinnamon, Andrew J.;
    • Pimiento, Jose M.;
    • Hodul, Pamela J.;
    • Kim, Dae Won
    Publication type:
    Article
    39
    40

    Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1790, doi. 10.3390/cancers17111790
    By:
    • Moiseenko, Fedor;
    • Radulovic, Marko;
    • Tsvetkova, Nadezhda;
    • Chernobrivceva, Vera;
    • Gabina, Albina;
    • Oganesian, Any;
    • Makarkina, Maria;
    • Elsakova, Ekaterina;
    • Krasavina, Maria;
    • Barsova, Daria;
    • Artemeva, Elizaveta;
    • Khenshtein, Valeria;
    • Levchenko, Natalia;
    • Chubenko, Viacheslav;
    • Egorenkov, Vitaliy;
    • Volkov, Nikita;
    • Bogdanov, Alexei;
    • Moiseyenko, Vladimir
    Publication type:
    Article
    41
    42
    43
    44

    Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1744, doi. 10.3390/cancers17111744
    By:
    • Lema, Laura;
    • Pérez-García, José Manuel;
    • Blanch, Salvador;
    • Balmaña, Judith;
    • García-Sáenz, José Ángel;
    • Vegas, Elena Filipovich;
    • Jiménez, Begoña;
    • de la Haba, Juan;
    • Campolier, Marta;
    • Shimizu, Eileen;
    • Alcalá-López, Daniel;
    • Sampayo-Cordero, Miguel;
    • Cortés, Javier;
    • Llombart-Cussac, Antonio
    Publication type:
    Article
    45
    46
    47
    48
    49

    Immunotherapy Applications in Urology.

    Published in:
    Journal of Urological Surgery, 2025, v. 12, n. 2, p. 1, doi. 10.4274/jus.galenos.2025.2024-11-9
    By:
    • Şenoğlu, Yusuf;
    • Şahin, Bahadır
    Publication type:
    Article
    50